ArticleAnnals of hematology2022
Correction to: Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real‑world, multi‑center, matched analysis.
Shai Shimony et al.PubMed ↗Publisher ↗
No numbers read from the abstract.